Compugen Ltd. - Ordinary Shares — Cash Flow (NASDAQ:CGEN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -28.32 M-22.75 M-34.51 M-35.89 M49.6 M31.63 M -17.94 M Cash from investing activities -82.17 M6.62 M37.06 M35.51 M-46.25 M30 M — Cash from financing activities 108.46 M16.84 M353 K3.08 M554 K10.6 M — Free cash flow -28.32 M-22.75 M-34.51 M-35.89 M49.6 M31.63 M -17.94 M

News

Compugen Ltd. (CGEN) Q1 2026 Earnings Call Transcript

Compugen (CGEN) Reports Q1 Loss, Lags Revenue Estimates

BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates

Adherex Technologies Inc. (FENC) Beats Q1 Earnings and Revenue Estimates

Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates

BioMarin Pharmaceutical (BMRN) Q1 Earnings Lag Estimates

Compugen at Leerink Global Healthcare Conference: Strategic Insights

Compugen Ltd. (CGEN) Q4 2025 Earnings Call Transcript

Morgan Stanley raises AstraZeneca stock price target on earnings growth

Compugen (CGEN) Beats Q4 Earnings and Revenue Estimates

Compugen earnings beat by $0.68, revenue topped estimates

Compugen stock jumps 5% on fourth quarter earnings beat